Early Clearance of Lactate and Its Outcome in Septic Patients: Lactate and Its Outcome in Septic Patients

Kafeel Ahmed; Zeeshan Ali

doi:10.54393/pjhs.v7i9.4257

Authors

Kafeel Ahmed Department of General Medicine, Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Zeeshan Ali Department of General Medicine, Jinnah Postgraduate Medical Centre, Karachi, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v7i9.4257

Keywords:

Lactic Acid, Multiple Organ Failure, Sepsis, Mortality

Abstract

Sepsis persists as a major cause of in-hospital mortality, with the highest burden in low- and middle-income countries. Early lactate clearance is proposed as a dynamic, low-cost biomarker of tissue perfusion, yet locally generated evidence from Pakistan is scarce. Objectives: To evaluate the frequency of early lactate clearance and its association with 30-day all-cause mortality and multiorgan failure in adults admitted with sepsis. Methods: This prospective cohort study with a 30-day follow-up was conducted in the Department of General Medicine, Jinnah Postgraduate Medical Centre, Karachi (14 October 2025 and 14 January 2026) after ethical approval. A total of 195 adults aged 18–65 years with Sepsis-3-defined sepsis and admission venous lactate >4 mmol/L were enrolled by consecutive sampling. Early lactate clearance was defined as a ≥10% reduction in venous lactate at 6 hours. Outcomes were SOFA-defined multiorgan failure and 30-day mortality. Continuous variables were summarized as median (IQR) after Shapiro-Wilk testing; binary logistic regression & survival analysis were performed. Results: Early lactate clearance occurred in 106/195 (54.4%) patients. Thirty-day mortality was significantly lower with clearance than without (12.3% vs 24.7%; OR 0.43, 95% CI 0.20–0.91; p=0.024), persisting after adjustment (aOR 0.43, 95% CI 0.20–0.94; p=0.035). Multiorgan failure did not differ significantly (17.0% vs 22.5%; OR 0.71, 95% CI 0.35–1.44; p=0.335). Conclusions: Early lactate clearance was associated with significantly lower 30-day mortality in this underpowered exploratory analysis; however, these findings require confirmation in larger adequately powered studies.

References

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Medicine. 2021 Nov; 47(11): 1181-247.

Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR et al. Global, Regional, and National Sepsis Incidence and Mortality, 1990–2017: Analysis for the Global Burden of Disease Study. The Lancet. 2020 Jan; 395(10219): 200-11. doi: 10.1016/S0140-6736(19)32989-7. DOI: https://doi.org/10.1016/S0140-6736(19)32989-7

Raza HA, Hashmi AP, Khakwani MM, Ali MH, Jamil B. Review of Sepsis in Pakistan: How Far Have We Come? International Society for Infectious Diseases Regions. 2024 Mar; 10: 108-13. doi: 10.1016/j.ijregi.2023.12.002. DOI: https://doi.org/10.1016/j.ijregi.2023.12.002

Barrak MH, Dawood FA, Abed Shubar SN, Al-Fahham AA. Pathophysiology, The Biochemical and Clinical Significance of Lactate Dehydrogenase. International Journal of Health and Medical Research. 2024; 3(07): 440-3. doi: 10.58806/ijhmr.2024.v3i07n02. DOI: https://doi.org/10.58806/ijhmr.2024.v3i07n02

Espinosa K and Brown SR. Serum Lactate Testing to Predict Mortality in Patients with Sepsis. American Family Physician. 2021 Mar; 103(5): 309-10.

Lee SG, Song J, Park DW, Moon S, Cho HJ, Kim JY et al. Prognostic Value of Lactate Levels and Lactate Clearance in Sepsis and Septic Shock with Initial Hyperlactatemia: A Retrospective Cohort Study According to the Sepsis-3 Definitions. Medicine. 2021 Feb; 100(7): e24835. doi: 10.1097/MD.0000000000024835. DOI: https://doi.org/10.1097/MD.0000000000024835

Sugimoto M, Takayama W, Murata K, Otomo Y. The Impact of Lactate Clearance on Outcomes According to Infection Sites in Patients with Sepsis: A Retrospective Observational Study. Scientific Reports. 2021 Nov; 11(1): 22394. doi: 10.1038/s41598-021-01856-5. DOI: https://doi.org/10.1038/s41598-021-01856-5

Tejaswini P, Singhai A, Pawar A, Joshi R, Saigal S, Pakhare AP. Study on Assessing Serum Lactate as an Early Prognostic Determinant in Sepsis Outcome. Cureus. 2024 Jan; 16(1). doi: 10.7759/cureus.52186. DOI: https://doi.org/10.7759/cureus.52186

Wang M, Wang Y, Taotao L, Zhao Q, Chao Y. Evaluation of Plasma Lactate Parameters for Predicting Mortality of Septic Patients. Heliyon. 2022 Dec; 8(12). doi: 10.1016/j.heliyon.2022.e12340. DOI: https://doi.org/10.1016/j.heliyon.2022.e12340

Lörstad S, Wang Y, Tehrani S, Shekarestan S, Åstrand P, Gille-Johnson P et al. Development of an Extended Cardiovascular SOFA Score Component Reflecting Cardiac Dysfunction with Improved Survival Prediction in Sepsis: An Exploratory Analysis in the Sepsis and Elevated Troponin (SET) Study. Journal of Intensive Care Medicine. 2025 Mar; 40(3): 320-30. doi: 10.1177/08850666241282294. DOI: https://doi.org/10.1177/08850666241282294

Vincent JL, Quintairos e Silva A, Couto Jr L, Taccone FS. The Value of Blood Lactate Kinetics in Critically Ill Patients: A Systematic Review. Critical Care. 2016 Aug; 20(1): 257. doi: 10.1186/s13054-016-1403-5. DOI: https://doi.org/10.1186/s13054-016-1403-5

McCallister R, Nuppnau M, Sjoding MW, Dickson RP, Chanderraj R. In patients with Sepsis, Initial Lactate Clearance Is Confounded Highly by Comorbidities and Poorly Predicts Subsequent Lactate Trajectory. Chest. 2023 Sep; 164(3): 667-9. doi: 10.1016/j.chest.2023.04.023. DOI: https://doi.org/10.1016/j.chest.2023.04.023

Alshiakh SM. Role of Serum Lactate as Prognostic Marker of Mortality among Emergency Department Patients with Multiple Conditions: A Systematic Review. SAGE Open Medicine. 2023 Jan; 11: 20503121221136401. doi: 10.1177/20503121221136401. DOI: https://doi.org/10.1177/20503121221136401

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Journal of the American Medical Association. 2016 Feb; 315(8): 801-10. doi: 10.1001/jama.2016.0287. DOI: https://doi.org/10.1001/jama.2016.0287

Rehman F, Zafar SB, Aziz A, Aziz A, Memon PS, Ejaz T et al. Early Lactate Clearance as a Determinant of Survival in Patients with Sepsis: Findings from a Low-Resource Country. The Journal of Critical Care Medicine. 2023 Feb; 9(1): 30. doi: 10.2478/jccm-2023-0005. DOI: https://doi.org/10.2478/jccm-2023-0005

Naing L, Nordin RB, Abdul Rahman H, Naing YT. Sample Size Calculation for Prevalence Studies Using Scalex and Scalar Calculators. BioMed Central Medical Research Methodology. 2022 Jul; 22(1): 209. doi: 10.1186/s12874-022-01694-7. DOI: https://doi.org/10.1186/s12874-022-01694-7

Diab R, Bou Chebl R, Barmo N, Siblini R, Makki M, Tamim H et al. Prognostic Utility of Procalcitonin and Lactate Clearance for in-Hospital Mortality in Sepsis. Frontiers in Medicine. 2025 Nov; 12: 1679297. doi: 10.3389/fmed.2025.1679297. DOI: https://doi.org/10.3389/fmed.2025.1679297

Trebuian CI, Marza AM, Chioibaş R, Şutoi D, Petrica A, Crintea-Najette I et al. Lactate Profile Assessment—A Good Predictor of Prognosis in Patients with COVID-19 and Septic Shock Requiring Continuous Renal Therapy. Clinics and Practice. 2024 May; 14(3): 980-94. doi: 10.3390/clinpract14030078. DOI: https://doi.org/10.3390/clinpract14030078

Dinakaran J, Yadav SS, Patel SK. Early Lactate Clearance in Predicting in-Hospital Mortality in Patients with Sepsis Admitted in the Pediatric Intensive Care Unit. Advances in Human Biology. 2023 Apr; 13(2): 187-91. doi: 10.4103/aihb.aihb_127_21. DOI: https://doi.org/10.4103/aihb.aihb_127_21

Falter F, Tisherman SA, Perrino AC, Kumar AB, Bush S, Nordstroem L et al. Serial Lactate in Clinical Medicine–A Narrative Review. Journal of Intensive Care Medicine. 2026 Mar; 41(3): 175-85. doi: 10.1177/08850666241303460. DOI: https://doi.org/10.1177/08850666241303460